Biomarker Technologies Market – Global Industry Analysis and Forecast (2023-2029)


Global Biomarker Technologies Market was valued at US$ 74.37 Bn. in 2022 and is expected to reach US$ 140.38 Bn. by 2029, at a CAGR of 9.5% during the forecast period.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.Biomarker Technologies MarketTo know about the Research Methodology :- Request Free Sample Report

Biomarker Technologies Market Dynamics

The biomarker is used as a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything such as gene, biological molecule, or characteristic that can be used as an indicator of a particular disease state or some other physiological state of a living organism. Biomarker technologies are used in Diagnosis, drug development, and formulation for a contact of definite unsafe chemical and prognostic treatments. The capability of biomarkers to diagnose at an early phase is widely used in cancer analysis and treatment. Biomarkers are using as indicators to estimate and compute pathogenic processes, pharmacological reactions, and biological processes.

The biomarker technologies market is expanding globally under the influence of factors such as increasing incidences of various diseases such as cancer, diabetes, cardiovascular and neurological disorders. National Cancer Institute (NCI) revealed that approximately 13,397,159 people were affected by various cancer types in the United States in 2011. According to the International Diabetes Federation (IDF), nearly 382 million people were living with diabetes from all over the world in 2013 and this number is expected to reach nearly 592 million by the end of 2035. China and India represent the first and second positions with a high prevalence of diabetes, 98.4 million and 65.1 million respectively.

The growth of the biomarkers market is highly driven by, increasing cases of diseases especially oncology-based disease, increasing demand for disease-specific biomarkers, growing adoption of personalized medicine. Moreover, an increasing utility of biomarkers for diagnostic purposes because of its accuracy, increasing healthcare expenditure, FDA support for biomarkers development, the government taking initiative in more biomarker research, increasing R&D funding by biotechnology companies and research institute, these factors will help to drive the market of biomarkers at xx% CAGR during the forecast period.

On the other hand, a huge amount of capital investment required for the discovery of biomarkers and their development and high cost of biomarkers, this factor may hamper the growth of the biomarkers market during the forecast period.

Segment Analysis:

Based on Product Type, the consumables segment accounted for the largest market share of biomarkers in 2022 and is expected to dominate over the others during the forecast period owing to the consumables play a key role in biomarker testing. The consumables market is further segmented into reagents & kits and chromatography columns. In 2022, the reagents & kits segment accounted for the largest share of the consumables market.

Biomarker Technologies Market

By Profiling Technology, the immunoassay segment accounted for the largest share in 2022 and is expected to drive the market of biomarkers in near future. This segment is further divided into ELISA, protein microarray, and western blot. In 2021, the ELISA segment accounted for the largest share of the immunoassay market. ELISA can quantify levels of multiple proteins and have the potential to accelerate the validation of protein biomarkers simultaneously for clinical use, these factors are helpful for the increasing use of ELISA in conformational studies in biomarker discovery.

The omics technology further divided into proteomics, genetics, and transcriptomics. Omics technology is used in the biomarker discovery technologies market. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting, and other molecular applications. The research area is vaster in omics technology

Regional Insights:

North America held the largest share of the biomarker technologies in 2022 attributed to the increasing prevalence of diseases such as cancer, autoimmune diseases, cardiovascular diseases & neurological diseases, increasing expenditure on health, and rising geriatric population, these are the factors responsible for the growth of the biomarker technologies market.

Europe had the second-largest market in 2022 and holds a healthy share in the global biomarker technologies market owing to the availability of advanced treatment facilities and established good healthcare infrastructure along with the growing need for efficient and accurate diagnosis and an increasing health expenditure the Asia Pacific is expected to register the highest growth rate from 2023 to 2029 for the biomarker technologies market. The rising incidence of cancer, growing geriatric population, and increasing funds in R&D from private and public organizations for biomarker research, are the factors that will drive the growth of the biomarker technologies market in the Asia Pacific region during the forecast period.

Recent Highlights in Global Biomarker Technologies Market

A group of chemists from UNSW Sydney’s Australian Centre for NanoMedicine (ACN) and biologists from UNSW's Lowy Cancer Research Centre have created a new sensor named “Nanopore blockade sensor” that can detect disease biomarkers in very low concentration in a short time.

The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Biomarker Technologies Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence.

Biomarker Technologies Market, Key Highlights:

Global Biomarker Technologies Market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Biomarker Technologies Market

Global Biomarker Technologies Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Biomarker Technologies Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Biomarker Technologies Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Biomarker Technologies Market are also profiled.

Biomarker Technologies Market Scope: Inquire before buying






Biomarker Technologies Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $74.37 Bn.




Forecast Period 2023 to 2029 CAGR:
9.5%
Market Size in 2029:
US $ 140.38 Bn.




 Segments Covered:
by Test Type
Solid Biopsy
Liquid Biopsy




by Technology
ddPCR
NGS
Immunoassay
Mass Spectrometry
DHPLC
Other Technologies




by Product
Consumables
Instruments
Services
Software/Informatics




by Research
Genomics
Proteomics
Metabolomics
Metabolic Flux
Lipidomics
Others
Other Research Areas




by Application
Drug Discovery
Diagnostics
Personalized Medicine






Biomarker Technologies Market by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)
South America (Brazil, Argetina and Rest of South America)

Biomarker Technologies Market Key Players:

1. Thermo Fisher Scientific
2. Bio-Rad Laboratories
3. Danaher Corporation
4. Agilent Technologies
5. Roche
6. Waters Corporation
7. Shimadzu Corporation
8. Illumina, Inc.
9. F. Hoffmann-La Roche AG
10. Merck KGAA
11. PerkinElmer Inc.
12. Siemens Healthcare
13. Abbott Laboratories
14. Qiagen N.V.
15. Biomérieux SA,
16. Becton,
17. Myriad Genetics,
18. Sysmex Corporation,
19. Quest Diagnostics
20. Aushon BioSystem Inc.,
21. Epistem Ltd.
22. Hologic

Frequently Asked Questions:

1. Which region has the largest share in Global Biomarker Technologies Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Biomarker Technologies Market?
Ans: The Global Biomarker Technologies Market is growing at a CAGR of 9.5% during forecasting period 2023-2029.

3. What is scope of the Global Biomarker Technologies market report?
Ans: Global Biomarker Technologies Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Biomarker Technologies market?
Ans: The important key players in the Global Biomarker Technologies Market are – Thermo Fisher Scientific, Bio-Rad Laboratories, Danaher Corporation, Agilent Technologies, Roche, Waters Corporation, Shimadzu Corporation, Illumina, Inc., F. Hoffmann-La Roche AG, Merck KGAA, PerkinElmer Inc., Siemens Healthcare, Abbott Laboratories, Qiagen N.V., Biomérieux SA,, Becton,, Myriad Genetics,, Sysmex Corporation,, Quest Diagnostics, Aushon BioSystem Inc.,, Epistem Ltd., and Hologic

5. What is the study period of this market?
Ans: The Global Biomarker Technologies Market is studied from 2022 to 2029. 





Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary : Global Biomarker Technologies Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends in Global Biomarker Technologies Market
4.8. Patent Registration

5. Supply Side and Demand Side Indicators

6. Global Biomarker Technologies Market Analysis and Forecast
6.1. Global Biomarker Technologies Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Biomarker Technologies Market Analysis and Forecast, by Test Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Biomarker Technologies Market Value Share Analysis, by Test Type
7.4. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Test Type
7.5. Global Biomarker Technologies Market Analysis, by Test Type
7.6. Global Biomarker Technologies Market Attractiveness Analysis, by Test Type

8. Global Biomarker Technologies Market Analysis and Forecast, by Technology
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Biomarker Technologies Market Value Share Analysis, by Technology
8.4. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Technology
8.5. Global Biomarker Technologies Market Analysis, by Technology
8.6. Global Biomarker Technologies Market Attractiveness Analysis, by Technology

9. Global Biomarker Technologies Market Analysis and Forecast, by Product
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Biomarker Technologies Market Value Share Analysis, by Product
9.4. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Product
9.5. Global Biomarker Technologies Market Analysis, by Product
9.6. Global Biomarker Technologies Market Attractiveness Analysis, by Product

10. Global Biomarker Technologies Market Analysis and Forecast, by Application
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Biomarker Technologies Market Value Share Analysis, by Application
10.4. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Application
10.5. Global Biomarker Technologies Market Analysis, by Application
10.6. Global Biomarker Technologies Market Attractiveness Analysis, by Application

11. Global Biomarker Technologies Market Analysis and Forecast, by Research Area
11.1. Introduction and Definition
11.2. Key Findings
11.3. Global Biomarker Technologies Market Value Share Analysis, by Research Area
11.4. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Research Area
11.5. Global Biomarker Technologies Market Analysis, by Research Area
11.6. Global Biomarker Technologies Market Attractiveness Analysis, by Research Area

12. Global Biomarker Technologies Market Analysis, by Region
12.1. Global Biomarker Technologies Market Value Share Analysis, by Region
12.2. Global Biomarker Technologies Market Size (US$ Bn) Forecast, by Region
12.3. Global Biomarker Technologies Market Attractiveness Analysis, by Region

13. North America Biomarker Technologies Market Analysis
13.1. Key Findings
13.2. North America Biomarker Technologies Market Overview
13.3. North America Biomarker Technologies Market Value Share Analysis, by Test Type
13.4. North America Biomarker Technologies Market Forecast, by Test Type
13.4.1. Solid Biopsy
13.4.2. Liquid Biopsy
13.5. North America Biomarker Technologies Market Value Share Analysis, by Technology
13.6. North America Biomarker Technologies Market Forecast, by Technology
13.6.1. ddPCR
13.6.2. NGS
13.6.3. Mass Spectrometry
13.6.4. DHPLC
13.6.5. Other Technologies
13.7. North America Biomarker Technologies Market Value Share Analysis, by Product
13.8. North America Biomarker Technologies Market Forecast, by Product
13.8.1. Consumables
13.8.2. Instruments
13.8.3. Services
13.8.4. Software/Informatics
13.9. North America Biomarker Technologies Market Value Share Analysis, by Application
13.10. North America Biomarker Technologies Market Forecast, by Application
13.10.1. Drug Discovery
13.10.2. Diagnostics
13.10.3. Personalized Medicine
13.11. North America Biomarker Technologies Market Value Share Analysis, by Research Area
13.12. North America Biomarker Technologies Market Forecast, by Research Area
13.12.1. Genomics
13.12.2. Proteomics
13.12.3. Metabolomics
13.12.3.1. Metabolic Flux
13.12.3.2. Lipidomics
13.12.3.3. Others
13.12.4. Other Research Areas
13.13. North America Biomarker Technologies Market Value Share Analysis, by Country
13.14. North America Biomarker Technologies Market Forecast, by Country
13.14.1. U.S.
13.14.2. Canada
13.15. North America Biomarker Technologies Market Analysis, by Country
13.16. U.S. Biomarker Technologies Market Forecast, by Test Type
13.16.1. Solid Biopsy
13.16.2. Liquid Biopsy
13.17. U.S. Biomarker Technologies Market Forecast, by Technology
13.17.1. ddPCR
13.17.2. NGS
13.17.3. Mass Spectrometry
13.17.4. DHPLC
13.17.5. Other Technologies
13.18. U.S. Biomarker Technologies Market Forecast, by Product
13.18.1. Consumables
13.18.2. Instruments
13.18.3. Services
13.18.4. Software/Informatics
13.19. U.S. Biomarker Technologies Market Forecast, by Application
13.19.1. Drug Discovery
13.19.2. Diagnostics
13.19.3. Personalized Medicine
13.20. U.S. Biomarker Technologies Market Forecast, by Research Area
13.20.1. Genomics
13.20.2. Proteomics
13.20.3. Metabolomics
13.20.3.1. Metabolic Flux
13.20.3.2. Lipidomics
13.20.3.3. Others
13.20.4. Other Research Areas
13.21. Canada Biomarker Technologies Market Forecast, by Test Type
13.21.1. Solid Biopsy
13.21.2. Liquid Biopsy
13.22. Canada Biomarker Technologies Market Forecast, by Technology
13.22.1. ddPCR
13.22.2. NGS
13.22.3. Mass Spectrometry
13.22.4. DHPLC
13.22.5. Other Technologies
13.23. Canada Biomarker Technologies Market Forecast, by Product
13.23.1. Consumables
13.23.2. Instruments
13.23.3. Services
13.23.4. Software/Informatics
13.24. Canada Biomarker Technologies Market Forecast, by Application
13.24.1. Drug Discovery
13.24.2. Diagnostics
13.24.3. Personalized Medicine
13.25. Canada Biomarker Technologies Market Forecast, by Research Area
13.25.1. Genomics
13.25.2. Proteomics
13.25.3. Metabolomics
13.25.3.1. Metabolic Flux
13.25.3.2. Lipidomics
13.25.3.3. Others
13.25.4. Other Research Areas
13.26. North America Biomarker Technologies Market Attractiveness Analysis
13.26.1. By Test Type
13.26.2. By Technology
13.26.3. By Product
13.26.4. By Application
13.26.5. By Research Area
13.27. PEST Analysis

14. Europe Biomarker Technologies Market Analysis
14.1. Key Findings
14.2. Europe Biomarker Technologies Market Overview
14.3. Europe Biomarker Technologies Market Value Share Analysis, by Test Type
14.4. Europe Biomarker Technologies Market Forecast, by Test Type
14.4.1. Solid Biopsy
14.4.2. Liquid Biopsy
14.5. Europe Biomarker Technologies Market Value Share Analysis, by Technology
14.6. Europe Biomarker Technologies Market Forecast, by Technology
14.6.1. ddPCR
14.6.2. NGS
14.6.3. Mass Spectrometry
14.6.4. DHPLC
14.6.5. Other Technologies
14.7. Europe Biomarker Technologies Market Value Share Analysis, by Product
14.8. Europe Biomarker Technologies Market Forecast, by Product
14.8.1. Consumables
14.8.2. Instruments
14.8.3. Services
14.8.4. Software/Informatics
14.9. Europe Biomarker Technologies Market Value Share Analysis, by Application
14.10. Europe Biomarker Technologies Market Forecast, by Application
14.10.1. Drug Discovery
14.10.2. Diagnostics
14.10.3. Personalized Medicine
14.11. Europe Biomarker Technologies Market Value Share Analysis, by Research Area
14.12. Europe Biomarker Technologies Market Forecast, by Research Area
14.12.1. Genomics
14.12.2. Proteomics
14.12.3. Metabolomics
14.12.3.1. Metabolic Flux
14.12.3.2. Lipidomics
14.12.3.3. Others
14.12.4. Other Research Areas
14.13. Europe Biomarker Technologies Market Value Share Analysis, by Country
14.14. Europe Biomarker Technologies Market Forecast, by Country
14.14.1. Germany
14.14.2. U.K.
14.14.3. France
14.14.4. Italy
14.14.5. Spain
14.14.6. Rest of Europe
14.15. Europe Biomarker Technologies Market Analysis, by Country
14.16. Germany Biomarker Technologies Market Forecast, by Test Type
14.16.1. Solid Biopsy
14.16.2. Liquid Biopsy
14.17. Germany Biomarker Technologies Market Forecast, by Technology
14.17.1. ddPCR
14.17.2. NGS
14.17.3. Mass Spectrometry
14.17.4. DHPLC
14.17.5. Other Technologies
14.18. Germany Biomarker Technologies Market Forecast, by Product
14.18.1. Consumables
14.18.2. Instruments
14.18.3. Services
14.18.4. Software/Informatics
14.19. Germany Biomarker Technologies Market Forecast, by Application
14.19.1. Drug Discovery
14.19.2. Diagnostics
14.19.3. Personalized Medicine
14.20. Germany Biomarker Technologies Market Forecast, by Research Area
14.20.1. Genomics
14.20.2. Proteomics
14.20.3. Metabolomics
14.20.3.1. Metabolic Flux
14.20.3.2. Lipidomics
14.20.3.3. Others
14.20.4. Other Research Areas
14.21. U.K. Biomarker Technologies Market Forecast, by Test Type
14.21.1. Solid Biopsy
14.21.2. Liquid Biopsy
14.22. U.K. Biomarker Technologies Market Forecast, by Technology
14.22.1. ddPCR
14.22.2. NGS
14.22.3. Mass Spectrometry
14.22.4. DHPLC
14.22.5. Other Technologies
14.23. U.K. Biomarker Technologies Market Forecast, by Product
14.23.1. Consumables
14.23.2. Instruments
14.23.3. Services
14.23.4. Software/Informatics
14.24. U.K. Biomarker Technologies Market Forecast, by Application
14.24.1. Drug Discovery
14.24.2. Diagnostics
14.24.3. Personalized Medicine
14.25. U.K. Biomarker Technologies Market Forecast, by Research Area
14.25.1. Genomics
14.25.2. Proteomics
14.25.3. Metabolomics
14.25.3.1. Metabolic Flux
14.25.3.2. Lipidomics
14.25.3.3. Others
14.25.4. Other Research Areas
14.26. France Biomarker Technologies Market Forecast, by Test Type
14.26.1. Solid Biopsy
14.26.2. Liquid Biopsy
14.27. France Biomarker Technologies Market Forecast, by Technology
14.27.1. ddPCR
14.27.2. NGS
14.27.3. Mass Spectrometry
14.27.4. DHPLC
14.27.5. Other Technologies
14.28. France Biomarker Technologies Market Forecast, by Product
14.28.1. Consumables
14.28.2. Instruments
14.28.3. Services
14.28.4. Software/Informatics
14.29. France Biomarker Technologies Market Forecast, by Application
14.29.1. Drug Discovery
14.29.2. Diagnostics
14.29.3. Personalized Medicine
14.30. France Biomarker Technologies Market Forecast, by Research Area
14.30.1. Genomics
14.30.2. Proteomics
14.30.3. Metabolomics
14.30.3.1. Metabolic Flux
14.30.3.2. Lipidomics
14.30.3.3. Others
14.30.4. Other Research Areas
14.31. Italy Biomarker Technologies Market Forecast, by Test Type
14.31.1. Solid Biopsy
14.31.2. Liquid Biopsy
14.32. Italy Biomarker Technologies Market Forecast, by Technology
14.32.1. ddPCR
14.32.2. NGS
14.32.3. Mass Spectrometry
14.32.4. DHPLC
14.32.5. Other Technologies
14.33. Italy Biomarker Technologies Market Forecast, by Product
14.33.1. Consumables
14.33.2. Instruments
14.33.3. Services
14.33.4. Software/Informatics
14.34. Italy Biomarker Technologies Market Forecast, by Application
14.34.1. Drug Discovery
14.34.2. Diagnostics
14.34.3. Personalized Medicine
14.35. Italy Biomarker Technologies Market Forecast, by Research Area
14.35.1. Genomics
14.35.2. Proteomics
14.35.3. Metabolomics
14.35.3.1. Metabolic Flux
14.35.3.2. Lipidomics
14.35.3.3. Others
14.35.4. Other Research Areas
14.36. Spain Biomarker Technologies Market Forecast, by Test Type
14.36.1. Solid Biopsy
14.36.2. Liquid Biopsy
14.37. Spain Biomarker Technologies Market Forecast, by Technology
14.37.1. ddPCR
14.37.2. NGS
14.37.3. Mass Spectrometry
14.37.4. DHPLC
14.37.5. Other Technologies
14.38. Spain Biomarker Technologies Market Forecast, by Product
14.38.1. Consumables
14.38.2. Instruments
14.38.3. Services
14.38.4. Software/Informatics
14.39. Spain Biomarker Technologies Market Forecast, by Application
14.39.1. Drug Discovery
14.39.2. Diagnostics
14.39.3. Personalized Medicine
14.40. Spain Biomarker Technologies Market Forecast, by Research Area
14.40.1. Genomics
14.40.2. Proteomics
14.40.3. Metabolomics
14.40.3.1. Metabolic Flux
14.40.3.2. Lipidomics
14.40.3.3. Others
14.40.4. Other Research Areas
14.41. Rest of Europe Biomarker Technologies Market Forecast, by Test Type
14.41.1. Solid Biopsy
14.41.2. Liquid Biopsy
14.42. Rest of Europe Biomarker Technologies Market Forecast, by Technology
14.42.1. ddPCR
14.42.2. NGS
14.42.3. Mass Spectrometry
14.42.4. DHPLC
14.42.5. Other Technologies
14.43. Rest of Europe Biomarker Technologies Market Forecast, by Product
14.43.1. Consumables
14.43.2. Instruments
14.43.3. Services
14.43.4. Software/Informatics
14.44. Rest Of Europe Biomarker Technologies Market Forecast, by Application
14.44.1. Drug Discovery
14.44.2. Diagnostics
14.44.3. Personalized Medicine
14.45. Rest Of Europe Biomarker Technologies Market Forecast, by Research Area
14.45.1. Genomics
14.45.2. Proteomics
14.45.3. Metabolomics
14.45.3.1. Metabolic Flux
14.45.3.2. Lipidomics
14.45.3.3. Others
14.45.4. Other Research Areas
14.46. Europe Biomarker Technologies Market Attractiveness Analysis
14.46.1. By Test Type
14.46.2. By Technology
14.46.3. By Product
14.46.4. By Application
14.46.5. By Research Area
14.47. PEST Analysis

15. Asia Pacific Biomarker Technologies Market Analysis
15.1. Key Findings
15.2. Asia Pacific Biomarker Technologies Market Overview
15.3. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Test Type
15.4. Asia Pacific Biomarker Technologies Market Forecast, by Test Type
15.4.1. Solid Biopsy
15.4.2. Liquid Biopsy
15.5. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Technology
15.6. Asia Pacific Biomarker Technologies Market Forecast, by Technology
15.6.1. ddPCR
15.6.2. NGS
15.6.3. Mass Spectrometry
15.6.4. DHPLC
15.6.5. Other Technologies
15.7. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Product
15.8. Asia Pacific Biomarker Technologies Market Forecast, by Product
15.8.1. Consumables
15.8.2. Instruments
15.8.3. Services
15.8.4. Software/Informatics
15.9. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Application
15.10. Asia Pacific Biomarker Technologies Market Forecast, by Application
15.10.1. Drug Discovery
15.10.2. Diagnostics
15.10.3. Personalized Medicine
15.11. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Research Area
15.12. Asia Pacific Biomarker Technologies Market Forecast, by Research Area
15.12.1. Genomics
15.12.2. Proteomics
15.12.3. Metabolomics
15.12.3.1. Metabolic Flux
15.12.3.2. Lipidomics
15.12.3.3. Others
15.12.4. Other Research Areas
15.13. Asia Pacific Biomarker Technologies Market Value Share Analysis, by Country
15.14. Asia Pacific Biomarker Technologies Market Forecast, by Country
15.14.1. China
15.14.2. India
15.14.3. Japan
15.14.4. ASEAN
15.14.5. Rest of Asia Pacific
15.15. Asia Pacific Biomarker Technologies Market Analysis, by Country
15.16. China Biomarker Technologies Market Forecast, by Test Type
15.16.1. Solid Biopsy
15.16.2. Liquid Biopsy
15.17. China Biomarker Technologies Market Forecast, by Technology
15.17.1. ddPCR
15.17.2. NGS
15.17.3. Mass Spectrometry
15.17.4. DHPLC
15.17.5. Other Technologies
15.18. China Biomarker Technologies Market Forecast, by Product
15.18.1. Consumables
15.18.2. Instruments
15.18.3. Services
15.18.4. Software/Informatics
15.19. China Biomarker Technologies Market Forecast, by Application
15.19.1. Drug Discovery
15.19.2. Diagnostics
15.19.3. Personalized Medicine
15.20. China Biomarker Technologies Market Forecast, by Research Area
15.20.1. Genomics
15.20.2. Proteomics
15.20.3. Metabolomics
15.20.3.1. Metabolic Flux
15.20.3.2. Lipidomics
15.20.3.3. Others
15.20.4. Other Research Areas
15.21. India Biomarker Technologies Market Forecast, by Test Type
15.21.1. Solid Biopsy
15.21.2. Liquid Biopsy
15.22. India Biomarker Technologies Market Forecast, by Technology
15.22.1. ddPCR
15.22.2. NGS
15.22.3. Mass Spectrometry
15.22.4. DHPLC
15.22.5. Other Technologies
15.23. India Biomarker Technologies Market Forecast, by Product
15.23.1. Consumables
15.23.2. Instruments
15.23.3. Services
15.23.4. Software/Informatics
15.24. India Biomarker Technologies Market Forecast, by Application
15.24.1. Drug Discovery
15.24.2. Diagnostics
15.24.3. Personalized Medicine
15.25. India Biomarker Technologies Market Forecast, by Research Area
15.25.1. Genomics
15.25.2. Proteomics
15.25.3. Metabolomics
15.25.3.1. Metabolic Flux
15.25.3.2. Lipidomics
15.25.3.3. Others
15.25.4. Other Research Areas
15.26. Japan Biomarker Technologies Market Forecast, by Test Type
15.26.1. Solid Biopsy
15.26.2. Liquid Biopsy
15.27. Japan Biomarker Technologies Market Forecast, by Technology
15.27.1. ddPCR
15.27.2. NGS
15.27.3. Mass Spectrometry
15.27.4. DHPLC
15.27.5. Other Technologies
15.28. Japan Biomarker Technologies Market Forecast, by Product
15.28.1. Consumables
15.28.2. Instruments
15.28.3. Services
15.28.4. Software/Informatics
15.29. Japan Biomarker Technologies Market Forecast, by Application
15.29.1. Drug Discovery
15.29.2. Diagnostics
15.29.3. Personalized Medicine
15.30. Japan Biomarker Technologies Market Forecast, by Research Area
15.30.1. Genomics
15.30.2. Proteomics
15.30.3. Metabolomics
15.30.3.1. Metabolic Flux
15.30.3.2. Lipidomics
15.30.3.3. Others
15.30.4. Other Research Areas
15.31. ASEAN Biomarker Technologies Market Forecast, by Test Type
15.31.1. Solid Biopsy
15.31.2. Liquid Biopsy
15.32. ASEAN Biomarker Technologies Market Forecast, by Technology
15.32.1. ddPCR
15.32.2. NGS
15.32.3. Mass Spectrometry
15.32.4. DHPLC
15.32.5. Other Technologies
15.33. ASEAN Biomarker Technologies Market Forecast, by Product
15.33.1. Consumables
15.33.2. Instruments
15.33.3. Services
15.33.4. Software/Informatics
15.34. ASEAN Biomarker Technologies Market Forecast, by Application
15.34.1. Drug Discovery
15.34.2. Diagnostics
15.34.3. Personalized Medicine
15.35. ASEAN Biomarker Technologies Market Forecast, by Research Area
15.35.1. Genomics
15.35.2. Proteomics
15.35.3. Metabolomics
15.35.3.1. Metabolic Flux
15.35.3.2. Lipidomics
15.35.3.3. Others
15.35.4. Other Research Areas
15.36. Rest of Asia Pacific Biomarker Technologies Market Forecast, by Test Type
15.36.1. Solid Biopsy
15.36.2. Liquid Biopsy
15.37. Rest of Asia Pacific Biomarker Technologies Market Forecast, by Technology
15.37.1. ddPCR
15.37.2. NGS
15.37.3. Mass Spectrometry
15.37.4. DHPLC
15.37.5. Other Technologies
15.38. Rest of Asia Pacific Biomarker Technologies Market Forecast, by Product
15.38.1. Consumables
15.38.2. Instruments
15.38.3. Services
15.38.4. Software/Informatics
15.39. Rest of Asia Pacific Biomarker Technologies Market Forecast, by Application
15.39.1. Drug Discovery
15.39.2. Diagnostics
15.39.3. Personalized Medicine
15.40. Rest of Asia Pacific Biomarker Technologies Market Forecast, by Research Area
15.40.1. Genomics
15.40.2. Proteomics
15.40.3. Metabolomics
15.40.3.1. Metabolic Flux
15.40.3.2. Lipidomics
15.40.3.3. Others
15.40.4. Other Research Areas
15.41. Asia Pacific Biomarker Technologies Market Attractiveness Analysis
15.41.1. By Test Type
15.41.2. By Technology
15.41.3. By Product
15.41.4. By Application
15.41.5. By Research Area
15.42. PEST Analysis

16. Middle East & Africa Biomarker Technologies Market Analysis
16.1. Key Findings
16.2. Middle East & Africa Biomarker Technologies Market Overview
16.3. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Test Type
16.4. Middle East & Africa Biomarker Technologies Market Forecast, by Test Type
16.4.1. Solid Biopsy
16.4.2. Liquid Biopsy
16.5. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Technology
16.6. Middle East & Africa Biomarker Technologies Market Forecast, by Technology
16.6.1. ddPCR
16.6.2. NGS
16.6.3. Mass Spectrometry
16.6.4. DHPLC
16.6.5. Other Technologies
16.7. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Product
16.8. Middle East & Africa Biomarker Technologies Market Forecast, by Product
16.8.1. Consumables
16.8.2. Instruments
16.8.3. Services
16.8.4. Software/Informatics
16.9. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Application
16.10. Middle East & Africa Biomarker Technologies Market Forecast, by Application
16.10.1. Drug Discovery
16.10.2. Diagnostics
16.10.3. Personalized Medicine
16.11. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Research Area
16.12. Middle East & Africa Biomarker Technologies Market Forecast, by Research Area
16.12.1. Genomics
16.12.2. Proteomics
16.12.3. Metabolomics
16.12.3.1. Metabolic Flux
16.12.3.2. Lipidomics
16.12.3.3. Others
16.12.4. Other Research Areas
16.13. Middle East & Africa Biomarker Technologies Market Value Share Analysis, by Country
16.14. Middle East & Africa Biomarker Technologies Market Forecast, by Country
16.14.1. GCC
16.14.2. South Africa
16.14.3. Rest of Middle East & Africa
16.15. Middle East & Africa Biomarker Technologies Market Analysis, by Country
16.16. GCC Biomarker Technologies Market Forecast, by Test Type
16.16.1. Solid Biopsy
16.16.2. Liquid Biopsy
16.17. GCC Biomarker Technologies Market Forecast, by Technology
16.17.1. ddPCR
16.17.2. NGS
16.17.3. Mass Spectrometry
16.17.4. DHPLC
16.17.5. Other Technologies
16.18. GCC Biomarker Technologies Market Forecast, by Product
16.18.1. Consumables
16.18.2. Instruments
16.18.3. Services
16.18.4. Software/Informatics
16.19. GCC Biomarker Technologies Market Forecast, by Application
16.19.1. Drug Discovery
16.19.2. Diagnostics
16.19.3. Personalized Medicine
16.20. GCC Biomarker Technologies Market Forecast, by Research Area
16.20.1. Genomics
16.20.2. Proteomics
16.20.3. Metabolomics
16.20.3.1. Metabolic Flux
16.20.3.2. Lipidomics
16.20.3.3. Others
16.20.4. Other Research Areas
16.21. South Africa Biomarker Technologies Market Forecast, by Test Type
16.21.1. Solid Biopsy
16.21.2. Liquid Biopsy
16.22. South Africa Biomarker Technologies Market Forecast, by Technology
16.22.1. ddPCR
16.22.2. NGS
16.22.3. Mass Spectrometry
16.22.4. DHPLC
16.22.5. Other Technologies
16.23. South Africa Biomarker Technologies Market Forecast, by Product
16.23.1. Consumables
16.23.2. Instruments
16.23.3. Services
16.23.4. Software/Informatics
16.24. South Africa Biomarker Technologies Market Forecast, by Application
16.24.1. Drug Discovery
16.24.2. Diagnostics
16.24.3. Personalized Medicine
16.25. South Africa Biomarker Technologies Market Forecast, by Research Area
16.25.1. Genomics
16.25.2. Proteomics
16.25.3. Metabolomics
16.25.3.1. Metabolic Flux
16.25.3.2. Lipidomics
16.25.3.3. Others
16.25.4. Other Research Areas
16.26. Rest of Middle East & Africa Biomarker Technologies Market Forecast, by Test Type
16.26.1. Solid Biopsy
16.26.2. Liquid Biopsy
16.27. Rest of Middle East & Africa Biomarker Technologies Market Forecast, by Technology
16.27.1. ddPCR
16.27.2. NGS
16.27.3. Mass Spectrometry
16.27.4. DHPLC
16.27.5. Other Technologies
16.28. Rest of Middle East & Africa Biomarker Technologies Market Forecast, by Product
16.28.1. Consumables
16.28.2. Instruments
16.28.3. Services
16.28.4. Software/Informatics
16.29. Rest of Middle East & Africa Biomarker Technologies Market Forecast, by Application
16.29.1. Drug Discovery
16.29.2. Diagnostics
16.29.3. Personalized Medicine
16.30. Rest of Middle East & Africa Biomarker Technologies Market Forecast, by Research Area
16.30.1. Genomics
16.30.2. Proteomics
16.30.3. Metabolomics
16.30.3.1. Metabolic Flux
16.30.3.2. Lipidomics
16.30.3.3. Others
16.30.4. Other Research Areas
16.31. Middle East & Africa Biomarker Technologies Market Attractiveness Analysis
16.31.1. By Test Type
16.31.2. By Technology
16.31.3. By Product
16.31.4. By Application
16.31.5. By Research Area
16.32. PEST Analysis

17. South America Biomarker Technologies Market Analysis
17.1. Key Findings
17.2. South America Biomarker Technologies Market Overview
17.3. South America Biomarker Technologies Market Value Share Analysis, by Test Type
17.4. South America Biomarker Technologies Market Forecast, by Test Type
17.4.1. Solid Biopsy
17.4.2. Liquid Biopsy
17.5. South America Biomarker Technologies Market Value Share Analysis, by Technology
17.6. South America Biomarker Technologies Market Forecast, by Technology
17.6.1. ddPCR
17.6.2. NGS
17.6.3. Mass Spectrometry
17.6.4. DHPLC
17.6.5. Other Technologies
17.7. South America Biomarker Technologies Market Value Share Analysis, by Product
17.8. South America Biomarker Technologies Market Forecast, by Product
17.8.1. Consumables
17.8.2. Instruments
17.8.3. Services
17.8.4. Software/Informatics
17.9. South America Biomarker Technologies Market Value Share Analysis, by Application
17.10. South America Biomarker Technologies Market Forecast, by Application
17.10.1. Drug Discovery
17.10.2. Diagnostics
17.10.3. Personalized Medicine
17.11. South America Biomarker Technologies Market Value Share Analysis, by Research Area
17.12. South America Biomarker Technologies Market Forecast, by Research Area
17.12.1. Genomics
17.12.2. Proteomics
17.12.3. Metabolomics
17.12.3.1. Metabolic Flux
17.12.3.2. Lipidomics
17.12.3.3. Others
17.12.4. Other Research Areas
17.13. South America Biomarker Technologies Market Value Share Analysis, by Country
17.14. South America Biomarker Technologies Market Forecast, by Country
17.14.1. Brazil
17.14.2. Mexico
17.14.3. Rest of South America
17.15. South America Biomarker Technologies Market Analysis, by Country
17.16. Brazil Biomarker Technologies Market Forecast, by Test Type
17.16.1. Solid Biopsy
17.16.2. Liquid Biopsy
17.17. Brazil Biomarker Technologies Market Forecast, by Technology
17.17.1. ddPCR
17.17.2. NGS
17.17.3. Mass Spectrometry
17.17.4. DHPLC
17.17.5. Other Technologies
17.18. Brazil Biomarker Technologies Market Forecast, by Product
17.18.1. Consumables
17.18.2. Instruments
17.18.3. Services
17.18.4. Software/Informatics
17.19. Brazil Biomarker Technologies Market Forecast, by Application
17.19.1. Drug Discovery
17.19.2. Diagnostics
17.19.3. Personalized Medicine
17.20. Brazil Biomarker Technologies Market Forecast, by Research Area
17.20.1. Genomics
17.20.2. Proteomics
17.20.3. Metabolomics
17.20.3.1. Metabolic Flux
17.20.3.2. Lipidomics
17.20.3.3. Others
17.20.4. Other Research Areas
17.21. Mexico Biomarker Technologies Market Forecast, by Test Type
17.21.1. Solid Biopsy
17.21.2. Liquid Biopsy
17.22. Mexico Biomarker Technologies Market Forecast, by Technology
17.22.1. ddPCR
17.22.2. NGS
17.22.3. Mass Spectrometry
17.22.4. DHPLC
17.22.5. Other Technologies
17.23. Mexico Biomarker Technologies Market Forecast, by Product
17.23.1. Consumables
17.23.2. Instruments
17.23.3. Services
17.23.4. Software/Informatics
17.24. Mexico Biomarker Technologies Market Forecast, by Application
17.24.1. Drug Discovery
17.24.2. Diagnostics
17.24.3. Personalized Medicine
17.25. Mexico Biomarker Technologies Market Forecast, by Research Area
17.25.1. Genomics
17.25.2. Proteomics
17.25.3. Metabolomics
17.25.3.1. Metabolic Flux
17.25.3.2. Lipidomics
17.25.3.3. Others
17.25.4. Other Research Areas
17.26. Rest of South America Biomarker Technologies Market Forecast, by Test Type
17.26.1. Solid Biopsy
17.26.2. Liquid Biopsy
17.27. Rest of South America Biomarker Technologies Market Forecast, by Technology
17.27.1. ddPCR
17.27.2. NGS
17.27.3. Mass Spectrometry
17.27.4. DHPLC
17.27.5. Other Technologies
17.28. Rest of South America Biomarker Technologies Market Forecast, by Product
17.28.1. Consumables
17.28.2. Instruments
17.28.3. Services
17.28.4. Software/Informatics
17.29. Rest of South America Biomarker Technologies Market Forecast, by Application
17.29.1. Drug Discovery
17.29.2. Diagnostics
17.29.3. Personalized Medicine
17.30. Rest of South America Biomarker Technologies Market Forecast, by Research Area
17.30.1. Genomics
17.30.2. Proteomics
17.30.3. Metabolomics
17.30.3.1. Metabolic Flux
17.30.3.2. Lipidomics
17.30.3.3. Others
17.30.4. Other Research Areas
17.31. South America Biomarker Technologies Market Attractiveness Analysis
17.31.1. By Test Type
17.31.2. By Technology
17.31.3. By Product
17.31.4. By Application
17.31.5. By Research Area
17.32. PEST Analysis

18. Company Profiles
18.1. Market Share Analysis, by Company
18.2. Competition Matrix
18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
18.2.2. New Product Launches and Product Enhancements
18.2.3. Market Consolidation
18.2.3.1. M&A by Regions, Investment and Applications
18.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
18.3. Company Profiles: Key Players
18.3.1. Thermo Fisher Scientific
18.3.1.1. Company Overview
18.3.1.2. Financial Overview
18.3.1.3. Product Portfolio
18.3.1.4. Business Strategy
18.3.1.5. Recent Developments
18.3.1.6. Company Footprint
18.3.2. Bio-Rad Laboratories
18.3.3. Danaher Corporation
18.3.4. Agilent Technologies
18.3.5. Roche
18.3.6. Waters Corporation
18.3.7. Shimadzu Corporation
18.3.8. Illumina, Inc.
18.3.9. F. Hoffmann-La Roche AG
18.3.10. Merck KGAA
18.3.11. PerkinElmer Inc.
18.3.12. Siemens Healthcare
18.3.13.Abbott Laboratories
18.3.14. Qiagen N.V.
18.3.15.Biomérieux SA,
18.3.16.Becton,
18.3.17. Myriad Genetics,
18.3.18. Sysmex Corporation,
18.3.20. Quest Diagnostics
18.3.21. Hologic

19. Primary Key Insights
  • INQUIRE BEFORE BUYING